Pacira Biosciences has authorized a share buyback program of up to $300 million. The developer of non-opioid pain relievers said Thursday the repurchase program replaces a previous $150 million ...

BioSciences announced its board of directors has authorized a share repurchase program of up to an aggregate of $300M of the ...

Enters into Agreement with Bradley L. Radoff and Michael TorokBOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals ...

In April 2025, the Board of Directors authorized the repurchase of up to $5B of the company’s common stock, replacing the previous ...

There's one tech titan that has long been a leader when it comes to share buybacks, repurchasing a jaw-dropping $695 billion ...

Montauk Renewables (NASDAQ:MNTK) has announced a new $5 million share repurchase program authorized by its Board of Directors ...

An update from RELX plc ( ($GB:REL) ) is now available. RELX PLC has announced the purchase of 258,484 of its own ordinary shares through UBS AG ...

Onex Corp. (Canada) has renewed its share repurchase program to buy back up to 10% of its issued shares over the course of a one-year period.

UBS Chairman Colm Kelleher on Thursday reiterated the Swiss bank's intention to repurchase shares to the tune of $3 billion ...

ING announced today that, as part of our €2.0 billion share buyback programme announced on 31 October 2024, in total 12,386,735 shares were repurchased during the week of 7 April 2025 up to and ...

Absa Bank aims to buy back these shares because they do not qualify as regulatory capital. Once repurchased, the preference ...